In the Cell Metabolism study, mice were treated with lipopolysaccharide (LPS), an inflammatory stimulus, which induces elevation of inflammatory signaling molecules like TNF-alpha, and this inflammatory response was attenuated by GLP-1 receptor agonist treatment.

factualpending

Speaker

Unidentified Speaker — GLP-1 Aren’t Just Weight Loss Drugs: A Provocative Discovery [5nGTUaqKmcY]

Evidence Quote

“they treated mice with a substance that causes inflammation lipopolysaccharide or LPS which can be measured inflammation can be measured by an increase in inflammatory signaling molecules like tnf Alpha and then they also treated some mice with a gp1 receptor Agonist and observed reduced inflammation in the glp1 treated mice”

Source

GLP-1 Aren’t Just Weight Loss Drugs: A Provocative Discovery— Nick Norwitz MD PhD
Created: 8/11/2026, 7:45:10 AM

Your notes

Loading notes...